October 2016

31st October, 2016HIV superinfection provides a platform for investigation into how the immune system responds to various viral strains and therefore can be used to understand...

28th October, 2016The HIV Envelope (Env) is surrounded by glycans which serve multiple purposes. One of the purposes of glycans is to evade anti-HIV neutralizing antibodies...

26th October, 2016Bacterial Vaginosis (BV) is condition caused by an imbalance between the “good” and “bad” bacteria in the female genital tract (FGT).

24th October, 2016Broadly neutralising antibodies (bnAbs) which target HIV have been found to develop more commonly in children than in adults.

20th October, 2016We recently caught up with Prof Thumbi Ndung'u at the HIV Research for Prevention Conference where he shared the latest findings in his lab with us.

19th October, 2016Dr Anthony Fauci presented data at a plenary session at the HIV R4P conference on antibody targeting of the α4β7 integrin in a novel mechanism to control HIV infection. Antiretroviral therapy (ART) has been widely used

17th October, 2016Curing HIV has proven difficult with only two reported cases of a functional cure. To add to this, there is still no effective HIV vaccine that has been developed.

14th October, 2016As humans age, their levels of pro-inflammatory cytokines such as tumour necrosis factor (TNF), IL1β and IL6 increase in the serum and tissues.

12th October, 2016Despite eradication attempts, up to 2 billion people in developing countries have chronic helminth infections.

10th October, 2016Although the mucosa forms one of the largest parts of the immune system, little was known about immunological memory in the mucosa and how it is able to protect